Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hussein I El-Subbagh

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 22, 2012
Substituted thiazoles VII. Synthesis and antitumor activity of certain 2-(substituted amino)-4-phenyl-1,3-thiazole analogsGhada S Hassan, Shahenda M El-Messery, Fatmah A M Al-Omary, et al.
European Journal of Medicinal Chemistry|February 1, 2022
Synthesis, biological evaluation, and molecular modeling simulations of new heterocyclic hybrids as multi-targeted anti-Alzheimer's agentsOmnia M Waly, Kareem M Saad, Hussein I El-Subbagh, et al.
European Journal of Medicinal Chemistry|November 8, 2011
Substituted thiazoles V. synthesis and antitumor activity of novel thiazolo[2,3-b]quinazoline and pyrido[4,3-d]thiazolo[3,2-a]pyrimidine analoguesFatmah A M Al-Omary, Ghada S Hassan, Shahenda M El-Messery, et al.
Archiv Der Pharmazie|May 24, 2022
Thiazole-based SARS-CoV-2 protease (COV M<sup>pro</sup> ) inhibitors: Design, synthesis, enzyme inhibition, and molecular modeling simulationsReham W Elsayed, Mohamed A Sabry, Hussein I El-Subbagh, et al.
Frontiers in Chemistry|November 29, 2023
Editorial: Recent advances in the research and development of kinase-inhibitory anticancer moleculesAhmed A Al-Karmalawy, Hussein I El-Subbagh, Liliya Logoyda, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 17, 2012
S-Phenyl 4-meth-oxy-benzothio-ateAdel S El-Azab, Alaa A-M Abdel-Aziz, Hussein I El-Subbagh, et al.
Journal of Medicinal Chemistry|September 6, 2011
Chiral indolo[3,2-f][3]benzazecine-type dopamine receptor antagonists: synthesis and activity of racemic and enantiopure derivativesDina Robaa, Christoph Enzensperger, Shams Eldin Abulazm, et al.
RSC Advances|May 26, 2023
Discovery of new pyridine heterocyclic hybrids; design, synthesis, dynamic simulations, and <i>in vitro</i> and <i>in vivo</i> breast cancer biological assaysMenna M Abdelshaheed, Hussein I El Subbagh, Mohamed A Tantawy, et al.
Archiv Der Pharmazie|May 3, 2005
Synthesis and in vitro antioxidant activity of some new fused pyridine analogsMohamed A Al-Omar, Khairia M Youssef, Magda A El-Sherbeny, et al.
Archiv Der Pharmazie|October 29, 2003
Synthesis, in vitro and in vivo evaluation of a delivery system for targeting anticancer drugs to the brainMagda A El-Sherbeny, Huda S Al-Salem, Maha A Sultan, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|September 22, 2012
Substituted thiazoles VII. Synthesis and antitumor activity of certain 2-(substituted amino)-4-phenyl-1,3-thiazole analogsGhada S Hassan, Shahenda M El-Messery, Fatmah A M Al-Omary, et al.
European Journal of Medicinal Chemistry|February 1, 2022
Synthesis, biological evaluation, and molecular modeling simulations of new heterocyclic hybrids as multi-targeted anti-Alzheimer's agentsOmnia M Waly, Kareem M Saad, Hussein I El-Subbagh, et al.
European Journal of Medicinal Chemistry|November 8, 2011
Substituted thiazoles V. synthesis and antitumor activity of novel thiazolo[2,3-b]quinazoline and pyrido[4,3-d]thiazolo[3,2-a]pyrimidine analoguesFatmah A M Al-Omary, Ghada S Hassan, Shahenda M El-Messery, et al.
Archiv Der Pharmazie|May 24, 2022
Thiazole-based SARS-CoV-2 protease (COV M<sup>pro</sup> ) inhibitors: Design, synthesis, enzyme inhibition, and molecular modeling simulationsReham W Elsayed, Mohamed A Sabry, Hussein I El-Subbagh, et al.
Frontiers in Chemistry|November 29, 2023
Editorial: Recent advances in the research and development of kinase-inhibitory anticancer moleculesAhmed A Al-Karmalawy, Hussein I El-Subbagh, Liliya Logoyda, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 17, 2012
S-Phenyl 4-meth-oxy-benzothio-ateAdel S El-Azab, Alaa A-M Abdel-Aziz, Hussein I El-Subbagh, et al.
Journal of Medicinal Chemistry|September 6, 2011
Chiral indolo[3,2-f][3]benzazecine-type dopamine receptor antagonists: synthesis and activity of racemic and enantiopure derivativesDina Robaa, Christoph Enzensperger, Shams Eldin Abulazm, et al.
RSC Advances|May 26, 2023
Discovery of new pyridine heterocyclic hybrids; design, synthesis, dynamic simulations, and <i>in vitro</i> and <i>in vivo</i> breast cancer biological assaysMenna M Abdelshaheed, Hussein I El Subbagh, Mohamed A Tantawy, et al.
Archiv Der Pharmazie|May 3, 2005
Synthesis and in vitro antioxidant activity of some new fused pyridine analogsMohamed A Al-Omar, Khairia M Youssef, Magda A El-Sherbeny, et al.
Archiv Der Pharmazie|October 29, 2003
Synthesis, in vitro and in vivo evaluation of a delivery system for targeting anticancer drugs to the brainMagda A El-Sherbeny, Huda S Al-Salem, Maha A Sultan, et al.
Pageof 6